C46H56N16O3S2 — CID 142845374
N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]sulfanylphenyl]-2-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-[4-(propanoylamino)phenyl]sulfanylpyrimidin-4-yl]amino]piperidin-1-yl]cyclopropane-1-carboxamide (PubChem CID 142845374) has the molecular formula C46H56N16O3S2 and a molecular weight of 945.20 g/mol. Its IUPAC name is N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]sulfanylphenyl]-2-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-[4-(propanoylamino)phenyl]sulfanylpyrimidin-4-yl]amino]piperidin-1-yl]cyclopropane-1-carboxamide.
| Compound Name | N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]sulfanylphenyl]-2-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-[4-(propanoylamino)phenyl]sulfanylpyrimidin-4-yl]amino]piperidin-1-yl]cyclopropane-1-carboxamide |
|---|---|
| PubChem CID | 142845374 |
| Molecular Formula | C46H56N16O3S2 |
| Molecular Weight | 945.20 g/mol |
| Exact Mass | 944.42 |
| IUPAC Name | N-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]sulfanylphenyl]-2-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-[4-(propanoylamino)phenyl]sulfanylpyrimidin-4-yl]amino]piperidin-1-yl]cyclopropane-1-carboxamide |
| SMILES | CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(NC3CCN(C4CC4C(=O)Nc4ccc(Sc5nc(NCCN6CCOCC6)cc(Nc6cc(C)[nH]n6)n5)cc4)CC3)n2)cc1 |
| InChI | InChI=1S/C46H56N16O3S2/c1-4-43(63)49-30-5-9-33(10-6-30)67-46-54-38(27-40(56-46)52-42-24-29(3)58-60-42)48-32-13-16-62(17-14-32)36-25-35(36)44(64)50-31-7-11-34(12-8-31)66-45-53-37(47-15-18-61-19-21-65-22-20-61)26-39(55-45)51-41-23-28(2)57-59-41/h5-12,23-24,26-27,32,35-36H,4,13-22,25H2,1-3H3,(H,49,63)(H,50,64)(H3,47,51,53,55,57,59)(H3,48,52,54,56,58,60) |
| InChIKey | KNSWGBCPQMODHO-UHFFFAOYSA-N |
| XLogP | 7.12 |
| TPSA | 230.95 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 67 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 945.20 |
| LogP ≤ 5 | 7.12 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 17 |